MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus Inc. (Nasdaq:CPTS), developer of the Essure procedure, the first and only non-incisional permanent birth control method available, has been named to Deloitte’s prestigious Technology Fast 500 Program. This is a ranking of the fastest growing technology, media, telecommunications and life sciences companies by Deloitte & Touche USA LLP, one of the nation’s leading professional services organizations. Rankings are based on the percentage revenue growth over five years from 2001–2005.
